Nancy Moreno
University of Carabobo
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Nancy Moreno.
Genetics and Molecular Biology | 2002
Nancy Moreno; José Antonio Martínez; Zorella Blanco; Leidys Osorio; Patrick Hackshaw
Seven polymorphic sites in the b-globin gene cluster were analyzed on a sample of 96 chromosomes of Venezuelan sickle cell patients from the State of Aragua. The Benin haplotype was predominant with a frequency of 0.479, followed by the Bantu haplotype (0.406); a minority of cases with other haplotypes was also identified: atypical Bantu A2 (0.042), Senegal (0.031), atypical Bantu A7 (0.021) and Saudi Arabia/Indian (0.021) haplotypes; however, the Cameroon haplotype was not identified in this study. Our results are in agreement with the historical records that establish Sudanese and Bantu origins for the African slaves brought into Venezuela.
FEBS Letters | 1984
Flor Herrera; Nancy Moreno; José Antonio Martínez
A cell‐free protein synthesizing system from a mutant of Saccharomyces cerevisiae translated exogenous mRNA in the presence of 2μM edeine, while a similar system from wild‐type strain was completely inhibited by the drug. The mutant ribosomes showed an affinity for [125I]edeine comparable to the wild‐type ribosomes, thereby suggesting that these macromolecules alone were not responsible for the edeine‐resistant capacity of the mutant.
Drug Metabolism and Personalized Therapy | 2016
Nancy Moreno; Carlos Flores-Angulo; Cecilia Villegas; Yuselin Mora
Abstract CYP2D6 is an important cytochrome P450 enzyme that plays an important role in the metabolism of about 25% of currently prescribed drugs. The presence of polymorphisms in the CYP2D6 gene may modulate enzyme level and activity, thereby affecting individual responses to pharmacological treatments. The most prevalent diseases in the admixed population from Venezuela are cardiovascular and cancer, whereas viral, bacterial and parasitic diseases, particularly malaria, are prevalent in Amerindian populations; in the treatment of these diseases, several drugs that are metabolized by CYP2D6 are used. In this work, we reviewed the data on CYP2D6 variability and predicted metabolizer phenotypes, in healthy volunteers of two admixed and five Amerindian populations from Venezuela. The Venezuelan population is very heterogeneous as a result of the genetic admixture of three major ethnical components: Europeans, Africans and Amerindians. There are noticeable inter-regional and inter-population differences in the process of mixing of this population. Hitherto, there are few published studies in Venezuela on CYP2D6; therefore, it is necessary to increase research in this regard, in particular to develop studies with a larger sample size. There is a considerable amount of work remaining before CYP2D6 is integrated into clinical practice in Venezuela.
FEBS Journal | 1984
Flor Herrera; Nancy Moreno; José Martínez
Comunidad y Salud | 2008
Leidys Osorio; Angel Gamboa; Juana Cortez; Nancy Moreno; María Fátima Baeta; José Antonio Martínez; Narviz Pulido; Sol Sánchez; Daniel Vivas; Manuel Rolo
Current Pharmacogenomics and Personalized Medicine (formerly Current Pharmacogenomics) | 2018
Cecilia Villegas; Carlos Flores-Angulo; José Antonio Martínez; Flor Herrera; Nancy Moreno
Revista de Obstetricia y Ginecología de Venezuela | 2015
Henry Aguiar; Naikoa Goñi; Lucy Pinto; Marifel Carrozza; Sandra Abou Orm; Heriberto Correia; Nancy Moreno; Flor Herrera
Revista Peruana de Medicina Experimental y Salud Pública | 2015
Carlos Flores-Angulo; Cecilia Villegas; Yuselin Mora; José Antonio Martínez; Teresa Oropeza; Nancy Moreno
Comunidad y Salud | 2015
Narviz Pulido; Leidys Osorio; Manuel Rolo; Nancy Moreno; José Martínez; Mileidy Linares; Yasmint Díaz; Cecilia Villegas; Yaniret Bravo; Mirian Hernández
Boletin De Malariologia Y Salud Ambiental | 2015
María del Carmen López Martínez; Carlos Espino; Nancy Moreno; Elina Rojas; Milena Mazzarri; Víctor Mijares; Flor Herrera